Global Single Nucleotide Polymorphism (SNP) Genotyping Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028

The global single nucleotide polymorphism (SNP) genotyping market is anticipated to grow at a considerable CAGR of 20.4% during the forecast period (2022-2028). SNP genotyping is a process of measuring genetic variations between several numbers of species. The major factor attributing to the growth of the global SNP genotyping market includes the increasing number of diagnostic procedures across the globe. According to the National Center for biotechnology information (NCBI), the estimated worth of the global diagnostic market is around $40 billion to $45 billion in 2016. Among these, the major countries with the large size of the diagnostic market are the US, Europe, and Japan with around $19 million, $14 million, and $4 billion respectively representing around 80% of global sales in the diagnostic market. Furthermore, the application of SNP genotyping in research is also increasing as it enables researchers to explore genetic variants including SNP, and large structural changes in DNA. It provides benefits to researchers by enabling a deeper understanding of disease etiology on a molecular level.

The use of SNP genotyping is also increasing due to several benefits offered by this process, including accuracy, cost-effective way, reduces false-positive results, and maximizes the capture of population structural differences, among others. The application of SNP genotyping is also increasing in animals as it provides a powerful resource for animal breeding programs. The SNP genotyping can be very useful for studying quantitative traits and genetic variations in animals, providing a new tool that can choose the best breeding animal. In addition, the application of SNP genotyping is also increasing in plants as it is widely used to identify the cis-regulatory variation. It is also used to discover genes linked to complex genetic features in plants giving information about the adaptation of particular plant species in a particular region.

(Get 15% Discount on Buying this Report)

Get Sample Copy of Global Single Nucleotide Polymorphism (SNP) Genotyping Market at:
https://orionmarketreports.com/request-sample/?id=104944&submit=Request+Sample%0D%0A

Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

• Segment Covered-
o By Type
o By Application

• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World

• Competitive Landscape- Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Beckman Coulter Inc., and F. Hoffmann-La Roche Ltd., among others.

Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

A full report of Global Single Nucleotide Polymorphism (SNP) Genotyping Market is available at:
https://orionmarketreports.com/global-single-nucleotide-polymorphism-snp-genotyping-market/104944/

Global SNP Genotyping Market Report by Segment

By Type
• Tranversion Genotyping
• Transition Genotyping

By Application
• Diagnostics
• Animals
• Plants
• Research
• Others

Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.